Seidenberg Beth C's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Oct 30, 2024
- Accession no.
- 0001415889-24-025746
- Filed
- Oct 30, 2024
- Trade date
- Oct 28, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $720.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Seidenberg Beth CCIK 0001184592 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | Class A Common Stock | SSaleDisposed | −14,798 | $48.01 | −$710,451.98 | 131,755 | Direct | |
| Oct 28, 2024 | Class A Common Stock | SSaleDisposed | −202 | $49.54 | −$10,007.08 | 131,553 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.